Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Guaifenesin recalled?

Yes — there is an active recall. 7 ongoing FDA recalls mention Guaifenesin (78 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Guaifenesin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Guaifenesin recalls on record

none so far in 2026; 78 on record, newest first
Class II · Moderate risk

Cold Relief

cGMP deviations

Terminated cGMP deviation Ultra Seal Corporation NDC 42961-112-03 D-0483-2022
Class II · Moderate risk

Ephedrine Plus

cGMP deviations

Terminated cGMP deviation Ultra Seal Corporation NDC 65193-320-24 D-0473-2022
Class II · Moderate risk

Chloresin

cGMP deviations

Terminated cGMP deviation Ultra Seal Corporation NDC 51532-0107-2 D-0468-2022
Class II · Moderate risk

Neogen-D

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 52083-699-16 D-1506-2019
Class II · Moderate risk

Sorbugen Nr

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 52083-660-16 D-1505-2019
Class II · Moderate risk

Tusslin

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 52083-622-16 D-1504-2019
Class II · Moderate risk

Double Tussin Dm

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 63708-121-04 D-1498-2019
Class II · Moderate risk

Robafen DM

CGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Preferred Pharmaceuticals, Inc NDC 68788-0841-01 D-1410-2019
Class II · Moderate risk

Extra Action Cough Syrup

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Torrent Pharma Inc D-1369-2019
Class II · Moderate risk

Cough Syrup

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Torrent Pharma Inc D-1368-2019
Class II · Moderate risk

Guaifenesin DAC Oral Solution

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Torrent Pharma Inc D-1364-2019
Class II · Moderate risk

Guaifenesin AC Cough Syrup

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Torrent Pharma Inc D-1363-2019
Class II · Moderate risk

Robafen DM Syrup

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Torrent Pharma Inc D-1351-2019
Class II · Moderate risk

Robafen AC Oral Solution

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Torrent Pharma Inc D-1350-2019